Innoviva, Inc. (INVA): Shareholders' Equity
$1.17B
As of 2025-12-31
$1.23B
As of 2026-06-30
+27.5%
3-year compound annual growth
+16.8%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.17B | +69.7% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $691.16M | n/a | 2026-02-25, Balance as of period end |
| No annual figure between 2022-12-31 and 2024-12-31. | |||
| 2022-12-31 | $565.79M | +36.4% | 2023-02-28, Balance as of period end |
| 2021-12-31 | $414.74M | -23.2% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $539.91M | +72.2% | 2022-03-17, Balance as of period end |
| 2019-12-31 | $313.50M | +104.1% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $153.58M | n/m | 2020-02-19, Balance as of period end |
| 2017-12-31 | -$242.86M | n/m | 2019-02-19, Balance as of period end |
| 2016-12-31 | -$352.99M | n/m | 2018-02-23, Balance as of period end |
| 2015-12-31 | -$342.64M | n/m | 2017-02-28, Balance as of period end |
| 2014-12-31 | -$223.35M | n/m | 2017-02-28, Balance as of period end |
| 2013-12-31 | $299.12M | +92.9% | 2016-02-24, Balance as of period end |
| 2012-12-31 | $155.03M | n/m | 2015-02-27, Balance as of period end |
| 2011-12-31 | -$87.05M | n/m | 2014-03-03, Balance as of period end |
| 2010-12-31 | -$22.42M | n/m | 2013-02-26, Balance as of period end |
| 2009-12-31 | -$188.99M | n/a | 2012-02-27, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Innoviva, Inc. (INVA) | 2025-12-31 | $1.17B | +69.7% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $166.95M | -3.7% |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | $6.40B | -37.9% |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | $189.48M | +20.3% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $715.50M | -14.9% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $161.55M | +0.3% |
| MannKind Corp (MNKD) | 2025-12-31 | -$51.02M | n/m |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $114.83M | +94.4% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | -$2.09B | n/m |
Compare INVA, ARDX, SVA, ARQT side by side · Screen every company in Pharmaceutical Preparations ↗